BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11045831)

  • 1. Improving the outcome for fatty acid oxidation disorders.
    Morris AA; Leonard JV
    J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):367-70. PubMed ID: 11045831
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited defects of mitochondrial fatty acid oxidation.
    Turnbull DM; Shepherd IM; Aynsley-Green A
    Biochem Soc Trans; 1988 Jun; 16(3):424-7. PubMed ID: 3181618
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of fatty acid oxidation.
    Nyhan WL
    N Engl J Med; 1988 Nov; 319(20):1344-6. PubMed ID: 3185637
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissecting the spectrum of fatty acid oxidation disorders.
    Stanley CA
    J Pediatr; 1998 Mar; 132(3 Pt 1):384-6. PubMed ID: 9544886
    [No Abstract]   [Full Text] [Related]  

  • 5. Reye syndrome versus defects in oxidation of fatty acids.
    Wilson BE; Anderson LW
    J Pediatr; 1986 Jan; 108(1):159. PubMed ID: 3944684
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty acid oxidation defects.
    von Döbeln U
    Acta Paediatr Suppl; 1993 Jun; 82 Suppl 389():88-90. PubMed ID: 8374203
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
    Tyni T; Pourfarzam M; Turnbull DM
    Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic crisis in an infant--is the problem in the mitochondria?].
    Tyni T; Pihko H
    Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
    Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
    Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
    Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
    Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental changes in the characteristics of peroxisomal fatty acid oxidation system in rat liver.
    Horie S; Ishii H; Suga T
    Life Sci; 1981 Oct; 29(16):1649-56. PubMed ID: 7311711
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis.
    Downing M; Allen JC; Bonham JR; Edwards RG; Manning NJ; Olpin SE; Pollitt RJ
    J Inherit Metab Dis; 1999 May; 22(3):289-92. PubMed ID: 10384389
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitochondrial beta-oxidation in human alcoholic liver disease.
    Eaton S; Record CO; Bartlett K
    Biochem Soc Trans; 1995 Aug; 23(3):497S. PubMed ID: 8566398
    [No Abstract]   [Full Text] [Related]  

  • 15. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects.
    Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R
    J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-chain acyl-coenzyme A dehydrogenase deficiency in mice.
    Wood PA; Amendt BA; Rhead WJ; Millington DS; Inoue F; Armstrong D
    Pediatr Res; 1989 Jan; 25(1):38-43. PubMed ID: 2919115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden child death and 'healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Duran M; Hofkamp M; Rhead WJ; Saudubray JM; Wadman SK
    Pediatrics; 1986 Dec; 78(6):1052-7. PubMed ID: 3786030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in mitochondrial beta-oxidation of fatty acids.
    Wood PA
    Curr Opin Lipidol; 1999 Apr; 10(2):107-12. PubMed ID: 10327278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 4-enoyl-CoA reductase activity in liver mitochondria of rats fed high-fed diets and its effect on fatty acid oxidation and the inhibitory action of pent-4-enoate.
    Borrebaek B; Osmundsen H; Christiansen EN; Bremer J
    FEBS Lett; 1980 Nov; 121(1):23-4. PubMed ID: 7461116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.